Nicot, F <br/><br/>
Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.  [electronic resource] 

 -  Journal of medical virology  Mar 2011 
 - 437-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9071 
<br/><br/><label>Standard No.: </label>10.1002/jmv.21976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--blood<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--complications<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--blood<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Prospective Studies<br/>Recombinant Proteins--blood<br/>Ribavirin--blood<br/>Treatment Outcome<br/>Viral Load